Let’s Talk Medtech

MD&M West is a tradeshow that boasts some of the best speakers in the medical device industry - and Let's Talk Medtech has snagged its keynote speaker, Jennifer Samproni for this can't miss episode. Jennifer is the Chief Technology Officer, of Health Solutions at Flex, and drops by to shed some light on her keynote speech - Transforming the Future of Patient Care with Human Machine Interfaces. She'll also talk about how artificial intelligence is changing healthcare; why contract manufacturing is booming; and give tips on navigating the medical device industry in this season opener of Let's Talk Medtech.

MD+DI's Senior Editor, Amanda Pedersen joins us for this episode of Let's Talk Medtech to look at what 2023 was for the medical device and diagnostics industry. The veteran journalist also dives into what the future might hold in 2024 for the industry.

Benjamin Zegarelli, counsel with Mintz, gives some important regulatory updates surrounding laboratory-developed tests, artificial intelligence, and software. Oh yeah, we talk about a little thing called EU MDR in this new episode of Let's Talk Medtech.

Surbhi Sarna began her journey into medtech when she had a health scare at the age of 13. The ordeal led her to founding nVision, a company focused on the detection of ovarian cancer. nVision was eventually acquired by Boston Scientific. Sarna joins us shortly before her keynote at BIOMEDevice Silicon Valley to discuss her journey into medtech and what it takes to be an entrepreneur in the industry.

How is medtech holding up in this tough economy? Are supply issues still a problem in the industry? What's the next big market for growth? Is medtech still healthy? EY's Jim Welch answers these questions and talks about the company's latest Pulse of the Industry report in this brand-new episode.

GE HealthCare started off 2023 by becoming a fully independent company. The company then wasted little time making acquisitions. Most recently, GE HealthCare was in the spotlight because of developments in Alzheimer's treatments that could potentially drive up the demand for the firm's imaging equipment. Jan Makela, President and CEO, of Imaging at GE HealthCare, joins us to talk about the company's success and how it plans to finish out the year, in this exciting new episode.

It's all about surgical robotics as AiM Medical Robotics, Founder & CEO Gregory Fischer, PH.D. joins us for this episode of Let's Talk Medtech. Dr. Fischer talks about the surgical robotics landscape and all of the cool things AiM Medical Robotics has been up to. Plus, he gives a preview of his upcoming keynote at BIOMEDevice Boston titled, "From Concept to Commercialization: It’s not brain surgery, or is it?"

Claire Smith, VP of global strategic marketing for Nevro, shares how the company's HFX iQ technology is using artificial intelligence to help treat chronic pain. Smith also shares some of her experiences in medtech sales and how the role of a medtech salesperson has changed over the years.

It's been a little more than a year since ZimeVie was launched from Zimmer Biomet. The dental and spine specialist has had to overcome some tough obstacles and find its footing. ZimVie's CEO, Vafa Jamali returns to Let's Talk Medtech to discuss the company's growth, tribulations, success, and why Europe has become a fertile market. You don't want to miss this exciting episode of Let's Talk Medtech.

Nicole Black, Phd., Vice President of Biomaterials and Innovation, at Desktop Health, drops by to discuss how new technological developments are transforming 3D printing from a method primarily used for prototyping into a reliable manufacturing method for end-use medical devices. Black is also a keynote speaker at BioMEDevice Boston, an event showcasing emerging technologies and trends from the medtech market, set to be held Sept. 20-21 at the Boston Convention & Exhibition Center.

Naomi Schwartz, the Senior Director for Cybersecurity Quality & Safety at Medcrypt, a medical device cybersecurity specialty firm, shares some interesting tidbits about FDA's upcoming Refuse-to-Accept (RTA) policy for Cyber Devices and Related Systems. The policy is effective Oct. 1 and Schwartz breaks down what the RTA will mean for medical device manufacturers and their FDA submissions.

Rachel Hall, EY's US Consulting Digital Health and Smart Health Experience Leader, joins us for this episode as we peel back the layers of digital health. Rachel will give her take on the landscape and how each player, patient, physician, and healthcare firm fit into the ecosystem. We also talk about something that's been on everyone's minds lately - and that's artificial intelligence. So join us for this episode of Let's Talk Medtech as we "crack" the digital health code.

Volta Medical is a company that has developed AI software solutions to assist cardiac electrophysiologists in treating atrial fibrillation (AF). Its technology focuses on mapping abnormal regions in the heart during AF procedures and providing cues to optimize the ablation strategy. Unlike other mapping technologies, Volta Medical takes a data-driven approach and aims to replicate the clinical expertise of physicians using machine learning and AI. The company recently completed enrollment for the TAILORED-AF clinical trial, which is a large-scale international trial involving multiple centers and physicians in five countries. The trial enrolled 374 patients who will be followed up for one year. The primary endpoint is freedom from AF after one procedure, with several secondary endpoints related to freedom from arrhythmia. The co-founder of Volta Medical, Theophile Mohr-Durdez, joins this episode of Let's Talk Medtech to talk about the company's technology, long-term goals, and the unique skillset he brings to the table thanks to his experience on stage.

Elucid is changing the way we think about cardiovascular health. To do this, the Boston-based company has appointed medtech veteran, Scott Huennekens as chairman of its board. Scott along with Elucid's CEO Blake Richards joins us for this episode to talk about how the company is changing the way we view cardiovascular health. Plus, Scott discusses his incredible career in this can't-miss episode.

In this episode of Let's Talk Medtech, Babson Diagnostics CEO David Stein discusses the company's progress toward commercialization. Babson has developed a model for diagnostic blood testing that maintains a high standard of accuracy, yet requires only one-tenth the sample size of traditional venipuncture methods. Babson also uses a proprietary blood collection device to collect the sample at a participating pharmacy, then the sample is processed back at Babson's labs.

Hyperfine's President & CEO Maria Sainz tells us how and why Swoop is changing the way we think about MRI's. Plus, she discusses her career in the medtech industry.

Foley & Lardner LLp's, Nathaniel Lacktman joins us for this episode of Let's Talk Medtech to give insight on whether the telemedicine boom the industry saw at the beginning of the pandemic still exists.

maxon's Peter van Beek delves into the latest miniaturization trends in medtech.

Penumbra CEO Adam Elsesser joins Let’s Talk Medtech to discuss the company's newest mechanical thrombectomy devices (Lightning Flash and Lightning Bolt), an ambitious revenue projection, and why failure is an acceptable option at his company.

Galen Robotics's CTO and co-founder Dave Saunders explains why true artificial intelligence in healthcare doesn't exist...yet.